Agilent Technologies, Inc. Stock

Stocks

A

US00846U1016

Advanced Medical Equipment & Technology

Market Closed - NYSE 16:02:51 2026-07-20 EDT 5-day change 1st Jan Change
130.26 USD -0.91% Intraday chart for Agilent Technologies, Inc. -3.00% -4.27%

Valuation: Agilent Technologies, Inc.

Market Cap 37.13B 32.54B 30.08B 27.66B 52.27B 3,580B 53.1B 359B 141B 1,751B 139B 136B 6,032B P/E 2026 *
25.3x
P/E 2027 * 22.2x
Enterprise Value 37.94B 33.25B 30.74B 28.26B 53.41B 3,658B 54.25B 367B 144B 1,790B 142B 139B 6,163B EV / Sales 2026 *
5.09x
EV / Sales 2027 * 4.65x
Free-Float
99.81%
Yield 2026 *
0.79%
Yield 2027 * 0.84%
07-20 HALO X-ray Technologies Ltd announced that it has received funding from Agilent Technologies, Inc., Future Planet Capital, British Business Investments Ltd., Future Planet Capital Limited CI
07-14 Agilent Technologies Receives Fda Approval for Pd-L1 Ihc 28-8 Pharmdx in Esophageal Squamous Cell Carcinoma, Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma CI
07-14 Agilent Wins FDA Approval for PD-L1 Test to Guide Bristol Myers' Opdivo Use in GI Cancers MT
07-13 Baird Adjusts Agilent Technologies Price Target to $160 From $158, Maintains Outperform Rating MT
07-08 Agilent Technologies Inc. Expands Altura Portfolio with Inert Size Exclusion and Plrp-S Columns for Biotherapeutic Analysis CI
07-06 Evercore ISI Adjusts Agilent Technologies PT to $148 From $144 MT
07-01 Agilent Technologies Launches Xcelligence RTCA Esight AI Module CI
06-26 Analyst recommendations: Crocs, Dell, On Semiconductor, Qualcomm, Micron… Zonebourse
06-25 Agilent Technologies, Inc. Closes $600 Million Private Placement Of 4.900% Senior Notes Due 2032 CI
06-25 Agilent Technologies, Inc. (NYSE:A) completed the acquisition of Biocare Medical, LLC from an investor group led by Excellere Capital Fund III LP, a fund managed by Excellere Capital Management LLC and GHO Capital Partners LLP. CI
06-25 Agilent Technologies Completes Purchase of Biocare Medical From Excellere-Led Investor Group MT
06-23 Barclays Adjusts Price Target on Agilent Technologies to $150 From $145, Maintains Overweight Rating MT
06-03 Trading Day: War clouds and tech wobbles RE
1 day-0.91%
1 week-3.00%
Current month-1.93%
1 month+2.52%
3 months+6.88%
6 months-6.72%
Current year-4.27%
1 week 130.16
Extreme 130.155
136.91
1 month 125.57
Extreme 125.57
138.62
Current year 108.35
Extreme 108.35
150.1
1 year 108.35
Extreme 108.35
160.27
3 years 96.43
Extreme 96.43
160.27
5 years 96.43
Extreme 96.43
179.57
10 years 42.92
Extreme 42.92
179.57
Manager TitleAgeSince
Chief Executive Officer 54 2024-02-20
Director of Finance/CFO 49 2025-11-16
Chief Operating Officer - 2025-09-30
Director TitleAgeSince
Chairman 75 2017-03-15
Director/Board Member 78 2010-12-31
Director/Board Member 72 2015-06-30
Date Insider Type Main position Quantity % Market Cap.
6/26/26 Tax

Executive/Senior Manager

-30 0.0000%
6/3/26 Tax

Chief Executive Officer

-418 0.0001%
6/2/26 Other

Controller/Auditor

8,872 0.0031%
Change 5-day change 1-year change 3-year change Capi.($)
-0.91%-3.00%+14.27%+5.83% 37.13B
-1.17%-0.16%+26.88%-1.74% 198B
-1.33%+1.03%+5.82%-17.54% 144B
+2.24%-13.18%-31.90%+0.99% 122B
-0.59%-2.23%-57.77%-16.37% 65.44B
-0.85%-7.82%+11.13%-7.23% 49.36B
+0.65%+2.20%-23.34%-30.88% 44.74B
-3.10%-5.02%+24.35%+27.66% 36.23B
-0.19%-2.58%-23.00%-8.92% 28.7B
-0.38%-2.89%-17.29%-23.14% 28.69B
Average -0.78%-2.78%-7.08%-7.13% 75.48B
Weighted average by Cap. -0.83%-2.61%-2.34%-6.97%

Financials

2026 *2027 *
Net sales 7.45B 6.53B 6.03B 5.55B 10.49B 718B 10.65B 72.03B 28.25B 351B 27.97B 27.36B 1,210B 7.9B 6.92B 6.4B 5.89B 11.12B 762B 11.3B 76.4B 29.96B 373B 29.67B 29.02B 1,284B
Net income 1.47B 1.28B 1.19B 1.09B 2.06B 141B 2.1B 14.17B 5.56B 69.14B 5.5B 5.38B 238B 1.63B 1.43B 1.32B 1.22B 2.3B 158B 2.34B 15.81B 6.2B 77.11B 6.14B 6B 266B
Net Debt 807M 708M 654M 601M 1.14B 77.85B 1.15B 7.81B 3.06B 38.08B 3.03B 2.97B 131B -401M -352M -325M -299M -565M -38.68B -574M -3.88B -1.52B -18.92B -1.51B -1.47B -65.16B
Logo Agilent Technologies, Inc.
Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry sectors. The activity is organized mainly around three families of products: - electronic measurement instruments; - bio-analytical measurement instruments: used to identify, quantify, and analyze the physical and biological properties of substances and products; - measurement instruments for semiconductors. Net sales break down by source of income between sales of products (71.2%) and services (28.8%). Net sales are distributed geographically as follows: the United States (33.7%), China and Hong Kong (17.6%) and other (48.7%).
Employees
18,000
Date Price Change Volume
26-07-20 US$130.26 -0.91% 2,468,964
26-07-17 US$131.46 -3.41% 4,247,327
26-07-16 US$136.10 +1.03% 1,752,036
26-07-15 US$134.71 -0.36% 1,909,131
26-07-14 US$135.20 +0.87% 1,683,906
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
131.46USD
Average target price
159.32USD
Spread / Average Target
+21.19%

Quarterly revenue - Rate of surprise